You are viewing a free summary from Descrybe.ai. For citation checking, legal issue analysis, and other advanced tools, explore our Legal Research Toolkit — not free, but close.

Pactive Corp. v. Dow Chemical Company

Citations: 449 F.3d 1227; 78 U.S.P.Q. 2d (BNA) 1939; 2006 U.S. App. LEXIS 13785; 2006 WL 1519988Docket: 2005-1260

Court: Court of Appeals for the Federal Circuit; June 5, 2006; Federal Appellate Court

Original Court Document: View Document

Narrative Opinion Summary

The case involves Pactiv Corporation's appeal against the dismissal of its declaratory judgment action seeking a determination of noninfringement, invalidity, and unenforceability of two U.S. patents held by Dow Chemical Company. Previously, in 1998, a Settlement and License Agreement was reached after Dow accused Pactiv of patent infringement. Pactiv ceased royalty payments in 2002 and filed for a declaratory judgment in 2003, claiming the patents were invalid. Dow moved to dismiss the action, citing res judicata due to the prior settlement. The district court upheld the dismissal, finding no reservation in the agreement allowing Pactiv to challenge the patents and concluding the claims were precluded. The Federal Circuit affirmed, applying res judicata and noting that Pactiv's breach of the License Agreement established jurisdiction for the declaratory judgment action. The court rejected Pactiv's arguments of material factual disputes and lack of a full and fair opportunity to litigate, emphasizing that the 1998 Agreement did not permit future challenges to the patents. The court also addressed Pactiv's claim of fraud during prior litigation, stating that such an argument needed to be raised via a Rule 60(b) motion in the original case. Ultimately, the court affirmed the lower court’s decision without costs, maintaining the enforceability of the settlement agreement and preclusion of Pactiv's claims under res judicata.

Legal Issues Addressed

Application of Res Judicata in Settlement Agreements

Application: The court applied res judicata to bar Pactiv's claims, as the 1998 Settlement and License Agreement did not reserve Pactiv's right to contest the patents, and the prior judgment was deemed enforceable.

Reasoning: The district court found that the 1998 Agreement did not reserve Pactiv's right to contest the patents and deemed the prior judgment enforceable, leading to the dismissal of Pactiv's claims.

Claim Preclusion under Second Circuit Law

Application: Claim preclusion was determined by the law of the Second Circuit, which holds that claims raised or that could have been raised in a previous action adjudicated on the merits are barred.

Reasoning: Claim preclusion issues in this case are determined by the law of the Second Circuit, as the case does not involve any specific patent rules.

Exceptions to Claim Preclusion

Application: The court found no exception to claim preclusion based on the agreement, as the 1998 Settlement did not explicitly allow Pactiv to challenge the patents in the future.

Reasoning: An exception to claim preclusion exists when parties agree that a plaintiff may split claims or a defendant acquiesces to this arrangement, allowing for claims that might otherwise be barred by res judicata to be preserved in a separate agreement.

Full and Fair Opportunity to Litigate and Res Judicata

Application: The claim that Pactiv was denied a full and fair opportunity to litigate due to alleged fabrication of evidence did not suffice to prevent the application of res judicata.

Reasoning: Pactiv argues that res judicata should not bar its current action due to being denied a full and fair opportunity to litigate the patents because Dow allegedly fabricated evidence during prior litigation.

Impact of Fraud on Res Judicata

Application: The court noted that fraud might serve as a defense against res judicata but emphasized that Pactiv needed to file a Rule 60(b) motion in the original case to challenge the judgment on such grounds.

Reasoning: The Restatement suggests that fraud might serve as a defense against res judicata in specific situations, particularly if essential aspects of a claim were not presented due to fraudulent actions.